Advertisement

---

Health Business news
2017-09-22
Global $94.6 Bn Contract Pharmaceutical Manufacturing Market, 2022

Global $94.6 Bn Contract Pharmaceutical Manufacturing Market, 2022



DUBLIN, September 22, 2017 /PRNewswire/ --

The "Global Contract Pharmaceutical Manufacturing Market - By Dose Formulation Type, Region - Market Size, Demand Forecasts, Industry Trends and Updates(2016-2022)" report has been added to Research and Markets' offering. Global Contract Pharmaceutical manufacturing market is estimated to reach $94.63 billion by 2022 from $65.55 billion in 2016, at a CAGR of 6.31% for the forecasted period. Solid dose formulation constituted 42% of the market in 2016.

Contract Pharmaceutical manufacturing is a process of outsourcing certain production activities to third party manufacturers. These manufacturers are given the chemical formulation by pharma companies. This type of contract manufacturing is witnessing a rising trend as more and more pharma companies are trying to focus more on R&D of drugs rather than getting involved in the production of drugs in order to gain competitive advantage in the business. This industry is classified into API manufacturing and Finished Dosage formulation(FDF) manufacturing. FDF formulation is further divided into solid dose formulation, liquid dose formulation and injectable dose formulation.

North America holds the major share in Global Contract Pharmaceutical manufacturing market. Asia-Pacific-especially India-is the fastest growing market. US, Canada, China, India, Japan and Australia are main countries operating in this industry.

Increasing consumption of medicines around the globe, aging population, increasing rate of approvals, adoption of novel manufacturing technologies, increasing demand for generic drugs, robust pipeline of drugs and increasing number of patent expires are some of the factors fuelling the growth of this industry.Availability of skilled workforce and lower labour cost are some of the factors propelling the rapid growth of Asia-Pacific market.Increasing complexity of clinical trials, lack of in-house laboratory capacity are some of the challenges in this industry.

Major companies operating in Contract Pharmaceutical manufacturing industry include HAUPT Pharma AG, Abbott Laboratories,Pfizer,Catalent Pharma Solutions, Althea Technologies and Nipro Corp.Several firms have acquired contract service providers to achieve vertical integration. Mergers and Acquisitions are also one of the key strategies being adopted by various companies.Pharma companies are also turning to contract packaging companies for novel packaging solutions. Also there is a transition from vertically integration to an ecosystem of interconnected suppliers by major players.
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Market Overview


Definition
Value Chain Analysis
Porter's 5 Forces
Regulations
4. Market Dynamics Introduction
Drivers
Constraints
Opportunities
5. Global Contract Pharmaceutical Manufacturing market Segmentation, Forecasts and Trends - By Revenue6. By Dose Formulation type Solid Dose Formulation
Liquid Dose Formulation
Injectable Dose Formulation
7. By Region North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Switzerland
Others
Asia-Pacific
China
India
Japan
Australia
Others
Latin America
Mexico
Brazil
Argentina
Others
MEA
UAE
Saudi Arabia
South Africa
Others
8. Vendor Market Share Analysis 9. Company Profiles Catalent Pharma Solutions
Lonza
Royal DSM
Patheon
Vetter Pharma
Patheon
Dr. Reddy's Laboratories
Euticals
Recipharm
Baxter BioPharma Solutions
Biomeva
Boehringer Ingelheim
Aenova
Jubilant
Zhejiang Hisun Pharmaceutical
Famar
Shandong Xinhua Pharmaceutical
Esteve Qumica
Evonik Degussa
Fareva
AbbVie Contract Manufacturing
Divis Laboratories
Aurobindo Pharma
Pfizer CentreSource
Nipro Corporation
Teva API
Daito Pharmaceutical
Others
10. Industry Structure Industry M&As, Consolidations
Investment Opportunities
11. Global Pharmaceutical Contract Manufacturing market - Road Ahead Tables
Disclaimer
For more information about this report visit https://www.researchandmarkets.com/research/m3ljmn/global_contract

Media Contact:

Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

 




Prev Article
Next Article

> Article Date par Research and Markets

Read: 4 views

Notes :

Source : PRN-International Desk

Advertisement

Related content

: Latest news

Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers